Skip to main content
Improved risk stratification in myeloma using a microRNA‐based classifier
Prognostic value of PTEN loss in men with conservatively managed localised prostate cancer
Erratum: Novel, gross chromosomal alterations involving PTEN cooperate with allelic loss in prostate cancer
Novel, gross chromosomal alterations involving PTEN cooperate with allelic loss in prostate cancer
Prognostic value of blood mRNA expression signatures in castration-resistant prostate cancer: a prospective, two-stage study
A HIF-Regulated VHL-PTP1B-Src Signaling Axis Identifies a Therapeutic Target in Renal Cell Carcinoma
A Gene Expression–Based Predictor for Myeloma Patients at High Risk of Developing Bone Disease on Bisphosphonate Treatment
siRNA Knockdown of Ribosomal Protein Gene RPL19 Abrogates the Aggressive Phenotype of Human Prostate Cancer
A census of amplified and overexpressed human cancer genes
Molecular characterisation of ERG, ETV1 and PTEN gene loci identifies patients at low and high risk of death from prostate cancer
-
Our research
-
Technology platforms
-
Training and events
-
Stories and impact
